The article by the Innovative Health Initiative (IHI) underscores the critical role of involving patients as active partners in healthcare research and innovation. Patient engagement has proven to be an essential element in the development of healthcare technologies and treatments that are truly effective and usable in real-world settings. When patients are involved early in the research and development process, they can provide valuable insights into the challenges and barriers they face, helping researchers design solutions that meet their actual needs rather than theoretical or clinical assumptions. 

The IHI emphasizes that for healthcare innovations to be truly transformative, they must be developed with the input of those they are intended to serve. For example, technologies that are intended to monitor chronic conditions, like diabetes or heart disease, must be accessible, easy to use, and adaptable to the everyday lives of patients. Involving patients in the co-design of these solutions ensures that they are not only clinically effective but also practical, helping to improve patient adherence and outcomes. 

The TARGET project is already fully aligned with the priorities outlined in the IHI article. As part of its commitment to advancing healthcare research, TARGET actively involves patients in the design and implementation of its studies. Through patient advisory boards, focus groups, and feedback loops, TARGET ensures that the solutions it develops are grounded in real-world patient experiences. This alignment guarantees that the project’s innovations will address the most pressing concerns faced by patients and healthcare providers, ensuring that they are both scientifically robust and practically applicable to everyday healthcare settings.